Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term esomeprazole for prevention of NSAID-associated gastric/duodenal ulcers
jRCT2080220543Phase 3
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of esomeprazole in gastric ulcer, duodenal ulcer and Peptic ulcer disease (PUD), sponsored by AstraZeneca.
02
Drugs
esomeprazole
03
Conditions
gastric ulcerduodenal ulcerPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080220543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220543.